Why are people with valvular heart disease in Saudi Arabia not getting treated?
Effective treatment is available, yet – despite a growing older population in Saudi Arabia – very few people receive aortic valve replacement annually.
The low number of patients treated annually in Saudi Arabia hints at missed opportunities and gaps in patient care, causing undetected and insufficiently treated degenerative VHD. A model was developed to estimate the burden of severe symptomatic aortic stenosis in the local population, using market-related data on treatment to better understand where patients “drop off” along the care pathway (Figure 3).
The patient drop-off demonstrates the urgent need for improvements in the health system to ensure that all patients with aortic stenosis receive the care they require.
Figure 3: The drop-off of patients with severe symptomatic aortic stenosis indicates the need for improved awareness, detection, and diagnosis in Saudi Arabia
Missed opportunities
Patients and their families fail to seek help, as they believe that their symptoms relate to natural aging.
The patient’s doctor or PCP fails to perform auscultation, thus missing the opportunity to diagnose aortic stenosis during a consultation.
The PCP performs the auscultation but does not refer the patient to a specialist to confirm the suspected diagnosis.
Around
20,000
people over the age of 65 years are estimated to live with symptoms of severe aortic stenosis in Saudi Arabia.*
Each year, around
1,900
Patients are referred by PCPs for diagnosis of a suspected heart murmur.** This indicates that a significant proportion of symptomatic severe aortic stenosis patients living with symptoms go unnoticed, or are not recognized as having VHD, or remain undetected by their doctor.21
Only
1,500
* Calculated based on published population figures (≥ 65 years Saudi nationals/non-nationals) and global prevalence data.46,47 A prevalence range of 1.7% to 2.6% has been factored into the analyses as a plausible estimate based on available literature. However, this range likely underestimates the true prevalence within the Saudi population. This underestimation is due to the high prevalence of comorbidities such as hypertension, dyslipidemia, diabetes, and obesity in Saudi Arabia, which are known to contribute to accelerated calcification of the aortic valve. Population-based epidemiological studies are critical to obtain more accurate estimates on the prevalence of severe aortic stenosis in Saudi Arabia. ** These estimates have been calculated based on expert opinion.